Ra Medical co-founder Burstein touts innovation, planning and caring as keys to success for medtech execs

This year has been an exciting one for Ra Medical, maker of the Dabra arteriosclerosis laser designed to treat peripheral artery disease. In May, the Carlsbad, Calif.-based company received a nod from the FDA for the Dabra, clearing it for sale in the US – something it had applied for approximately three years prior. And in September, the company revealed plans for a new funding round looking to raise up to $15 million to support the newly cleared technology. The path to commercialization has been a long, and satisfying, journey for co-founder and executive vice president Melissa Burstein. She credits the company’s belief in their product and a culture that prizes innovation for its success. “We are pleasantly surprised with the demand for our Dabra product and we see day in and day out that it has a true and intrinsic value for the operators that are running cath labs and performing the procedure. The patient results are phenomenal,” Burstein told MassDevice.com in an interview. “We are making tremendous strides creating greater value and increasing the value of our company.” In terms of her own accomplishments, Burstein said that a combination of planning, a focus on innovation and the integration of caring into her every day life has helped her succeed. Before helping co-found Ra Medical in 2002, Burstein dipped her toes into a number of different industries, seeking one that would be a good match for her personality and motivations. &...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Ra Medical Source Type: news